Cargando…
Development and validation of a risk assessment scale for pathological scarring
To develop a risk assessment scale for pathological scarring and validate its psychometric properties. This was a methodological study. Researchers developed the scale based on a literature review, qualitative study and Delphi expert consultation. Subsequently, 409 patients participated in the study...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10588301/ https://www.ncbi.nlm.nih.gov/pubmed/37211352 http://dx.doi.org/10.1111/iwj.14241 |
_version_ | 1785123551677775872 |
---|---|
author | Wang, Yanqiong Liu, Ruiqi Wu, Zhihui Xu, Xuewen He, Lingxiao |
author_facet | Wang, Yanqiong Liu, Ruiqi Wu, Zhihui Xu, Xuewen He, Lingxiao |
author_sort | Wang, Yanqiong |
collection | PubMed |
description | To develop a risk assessment scale for pathological scarring and validate its psychometric properties. This was a methodological study. Researchers developed the scale based on a literature review, qualitative study and Delphi expert consultation. Subsequently, 409 patients participated in the study to test the psychometric properties of the scale. We evaluated construct validity, content validity, internal consistency reliability, and interrater reliability. The researchers developed a scale consisting of three dimensions and 12 items. Factor analysis extracted a total of four common factors that accounted for 62.22% of the total variance. The results revealed that the item‐content validity index (I‐CVI) ranged from 0.67 to 1, while the scale‐content validity index (S‐CVI) was 0.82. Internal consistency reliability: Cronbach's α of the items ranged from 0.67 to 0.76, while Cronbach's α of the whole scale was 0.74. Interrater reliability: the Kappa number was 0.73. The final scale showed adequate construct validity, content validity, and reliability. It is appropriate for use in research and clinical practice settings to identify patients with a risk of pathological scarring. Further study is needed to confirm the scale's validity and reliability in other settings and populations. |
format | Online Article Text |
id | pubmed-10588301 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Blackwell Publishing Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-105883012023-10-21 Development and validation of a risk assessment scale for pathological scarring Wang, Yanqiong Liu, Ruiqi Wu, Zhihui Xu, Xuewen He, Lingxiao Int Wound J Original Articles To develop a risk assessment scale for pathological scarring and validate its psychometric properties. This was a methodological study. Researchers developed the scale based on a literature review, qualitative study and Delphi expert consultation. Subsequently, 409 patients participated in the study to test the psychometric properties of the scale. We evaluated construct validity, content validity, internal consistency reliability, and interrater reliability. The researchers developed a scale consisting of three dimensions and 12 items. Factor analysis extracted a total of four common factors that accounted for 62.22% of the total variance. The results revealed that the item‐content validity index (I‐CVI) ranged from 0.67 to 1, while the scale‐content validity index (S‐CVI) was 0.82. Internal consistency reliability: Cronbach's α of the items ranged from 0.67 to 0.76, while Cronbach's α of the whole scale was 0.74. Interrater reliability: the Kappa number was 0.73. The final scale showed adequate construct validity, content validity, and reliability. It is appropriate for use in research and clinical practice settings to identify patients with a risk of pathological scarring. Further study is needed to confirm the scale's validity and reliability in other settings and populations. Blackwell Publishing Ltd 2023-05-21 /pmc/articles/PMC10588301/ /pubmed/37211352 http://dx.doi.org/10.1111/iwj.14241 Text en © 2023 The Authors. International Wound Journal published by Medicalhelplines.com Inc and John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Original Articles Wang, Yanqiong Liu, Ruiqi Wu, Zhihui Xu, Xuewen He, Lingxiao Development and validation of a risk assessment scale for pathological scarring |
title | Development and validation of a risk assessment scale for pathological scarring |
title_full | Development and validation of a risk assessment scale for pathological scarring |
title_fullStr | Development and validation of a risk assessment scale for pathological scarring |
title_full_unstemmed | Development and validation of a risk assessment scale for pathological scarring |
title_short | Development and validation of a risk assessment scale for pathological scarring |
title_sort | development and validation of a risk assessment scale for pathological scarring |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10588301/ https://www.ncbi.nlm.nih.gov/pubmed/37211352 http://dx.doi.org/10.1111/iwj.14241 |
work_keys_str_mv | AT wangyanqiong developmentandvalidationofariskassessmentscaleforpathologicalscarring AT liuruiqi developmentandvalidationofariskassessmentscaleforpathologicalscarring AT wuzhihui developmentandvalidationofariskassessmentscaleforpathologicalscarring AT xuxuewen developmentandvalidationofariskassessmentscaleforpathologicalscarring AT helingxiao developmentandvalidationofariskassessmentscaleforpathologicalscarring |